Clearside Biomedical, Inc. Sales Agreements
2 Contracts & Agreements
- Controlled Equity OfferingSM Sales Agreement, dated as of May 12, 2023, by and between the Company and Cantor Fitzgerald & Co (Filed With SEC on May 12, 2023)
- CLEARSIDE BIOMEDICAL, INC. $50,000,000 COMMONSTOCK SALES AGREEMENT (Filed With SEC on July 3, 2017)
